$112.62
In chiusura: Sep 29 EDT
$112.84
0.220.20%
Pre-mercato: 6:52 PM EDT
Gilead Sciences fornisce indicazioni su EPS e ricavi futuri, offrendo agli investitori informazioni su quanto la società prevede di guadagnare nei prossimi periodi.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
08/07/2025 | GILD | Gilead Sciences | FY | 2025 | $7.95 | $8.25 | $8.01 | $28.30B | $28.70B | $28.71B | |
04/24/2025 | GILD | Gilead Sciences | FY | 2025 | $7.70 | $8.10 | $7.95 | $28.20B | $28.60B | $28.73B | |
02/11/2025 | GILD | Gilead Sciences | FY | 2025 | $7.70 | $8.10 | $7.60 | $28.20B | $28.60B | $28.41B | |
11/06/2024 | GILD | Gilead Sciences | FY | 2024 | $4.25 | $4.45 | $3.81 | $27.80B | $28.10B | $27.72B | |
08/08/2024 | GILD | Gilead Sciences | FY | 2024 | $3.60 | $3.90 | $3.75 | $27.10B | $27.50B | $27.58B | |
04/25/2024 | GILD | Gilead Sciences | FY | 2024 | $3.45 | $3.85 | $3.67 | $27.10B | $27.50B | $25.69B | |
02/06/2024 | GILD | Gilead Sciences | FY | 2024 | $6.85 | $7.25 | $7.21 | $27.10B | $27.50B | $27.66B | |
11/07/2023 | GILD | Gilead Sciences | FY | 2023 | $6.65 | $6.85 | $6.25 | $26.70B | $26.90B | $25.34B | |
08/03/2023 | GILD | Gilead Sciences | FY | 2023 | $6.45 | $6.80 | $6.73 | $26.30B | $26.70B | $26.66B | |
04/27/2023 | GILD | Gilead Sciences | FY | 2023 | $6.60 | $7.00 | $6.84 | $26.00B | $26.50B | $26.73B | |
02/02/2023 | GILD | Gilead Sciences | FY | 2023 | $6.60 | $7.00 | $6.73 | $26.00B | $26.50B | $25.76B | |
10/27/2022 | GILD | Gilead Sciences | FY | 2022 | $6.95 | $7.15 | $6.54 | $25.90B | $26.20B | $25.25B | |
08/02/2022 | GILD | Gilead Sciences | FY | 2022 | $6.35 | $6.75 | $6.57 | $24.50B | $25.00B | $24.57B | |
04/28/2022 | GILD | Gilead Sciences | FY | 2022 | $6.20 | $6.70 | $6.50 | $23.80B | $24.30B | $24.48B | |
02/01/2022 | GILD | Gilead Sciences | FY | 2022 | $6.20 | $6.70 | $6.91 | $23.80B | $24.30B | $24.39B | |
10/28/2021 | GILD | Gilead Sciences | FY | 2021 | $7.90 | $8.10 | $7.18 | $26.00B | $26.30B | $25.12B | |
07/29/2021 | GILD | Gilead Sciences | FY | 2021 | $6.90 | $7.25 | $7.07 | $24.40B | $25.00B | $24.64B | |
04/29/2021 | GILD | Gilead Sciences | FY | 2021 | $6.75 | $7.45 | $7.17 | $21.70B | $22.10B | $24.78B | |
02/04/2021 | GILD | Gilead Sciences | FY | 2021 | $6.75 | $7.45 | $6.85 | $21.70B | $22.10B | $24.27B | |
01/11/2021 | GILD | Gilead Sciences | FY | 2020 | $6.98 | $7.08 | $6.61 | $24.30B | $24.35B | $23.71B |
Le ultime previsioni per Gilead Sciences (GILD) sono state riportate il agosto 7, 2025 per l'intero anno 2025. L'azienda ha fornito una previsione di utili per azione nell'intervallo da $7.95 a $8.25, rispetto all'EPS stimato di $8.01. Inoltre, Gilead Sciences ha previsto ricavi tra $28.30B e $28.70B per il trimestre.
Sfoglia guidance e previsioni su tutte le azioni.